Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients.
NCT05226533 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 1
Last updated 2023-02-10
Summary
Safety and efficacy of DWRX2003 combination with Remdesivir in moderate to severe COVID-19 patients will be confirmed.
Conditions
Interventions
- DRUG
-
DWRX2003
Intramuscular injection of DWRX2003
- DRUG
-
Intramuscular injection of placebo
Sponsors & Collaborators
-
Daewoong Pharmaceutical Co. LTD.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-03-31
- Primary Completion
- 2022-12-16
- Completion
- 2022-12-21
Countries
- Indonesia
Study Locations
More Related Trials
-
A Study of DWJ1248 in Prevention of COVID-19 Infection After the Exposure of SARS-COV-2
NCT04721535 ·Status: TERMINATED ·Phase: PHASE3
-
COVID-19 and Anti-CD14 Treatment Trial
NCT04391309 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy and Safety of hzVSFv13 in Patients With COVID-19 Pneumonia
NCT04679350 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Merimepodib in Combination With Remdesivir in Adult Patients With Advanced COVID-19
NCT04410354 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Remdesivir (GS-5734™) Treatment of Coronavirus Disease 2019 (COVID-19) in an Outpatient Setting
NCT04501952 ·Status: TERMINATED ·Phase: PHASE3
-
Study in Participants With Early Stage Coronavirus Disease 2019 (COVID-19) to Evaluate the Safety, Efficacy, and Pharmacokinetics of Remdesivir Administered by Inhalation
NCT04539262 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)
NCT04745351 ·Status: TERMINATED ·Phase: PHASE3
-
Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
NCT06729593 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ES16001 in Patients With COVID-19
NCT05525182 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever
NCT04906980 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability and Clinical Effect of Danirixin in Adults With Influenza
NCT02469298 ·Status: COMPLETED ·Phase: PHASE2
-
A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine
NCT05067933 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Immunogenicity of the Candidate Vaccine MVA-MERS-S_DF-1 Against MERS
NCT04119440 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Efficacy and Safety of Leronlimab for Mild to Moderate COVID-19
NCT04343651 ·Status: COMPLETED ·Phase: PHASE2
-
Study on Safety and Clinical Efficacy of AZVUDINE in Initial Stage COVID-19 Patients (SARS-CoV-2 Infected)
NCT05033145 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Molnupiravir (MK-4482) in Hospitalized Adult Participants With COVID-19 (MK-4482-001)
NCT04575584 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
A Clinical Evaluation of the Safety and Efficacy of Randomized Placebo Versus the 8-aminoquinoline Tafenoquine for Early Symptom Resolution in Patients With Mild to Moderate COVID 19 Disease and Low Risk of Disease Progression
NCT05947812 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of RAY1216 Tablets Compared With Placebo in Patients With Mild to Moderate COVID-19
NCT05620160 ·Status: COMPLETED ·Phase: PHASE3
-
Singapore SARS-CoV-2 Human Challenge Study
NCT06654973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Phase IIa Randomized Placebo Controlled Clinical Study of Codivir in Hospitalized Patients with Moderate COVID-19
NCT05218356 ·Status: RECRUITING ·Phase: PHASE2
-
Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients
NCT04535856 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection
NCT05047601 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Efficacy,Immunogenicity and Safety of COVID-19 Vaccine , Inactivated Booster Dose in Adults Aged 18 Years and Above
NCT05156632 ·Status: WITHDRAWN ·Phase: PHASE3
-
The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19
NCT06349655 ·Status: COMPLETED
-
Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons [German: Prophylaxe Der COVID-19-Erkrankung Mit Ivermectin Bei COVID-19 Kontaktpersonen]
NCT05060666 ·Status: UNKNOWN ·Phase: PHASE3